SECTOR ANALYSIS

Endocrinology Oncology Biotech Companies

Grades, scores, and FDA catalyst signals for Endocrinology Oncology stocks tracked by BiotechSign

← Full ScreenerFDA CalendarAll Sectors
Companies
37
Avg Score
45
Top Grade
C
Endocrinology Oncology Companies37 tracked
TickerCompanyScoreGradeSectorSignals
BGNEBeiGene Ltd63COncology
DCPHDeciphera Pharmaceuticals63COncology
TOIThe Oncology Institute, Inc.61COncology
KURAKura Oncology, Inc.60COncology
SNDXSyndax Pharmaceuticals58COncology
NUVBNuvation Bio57COncology
NUVLNuvalent Inc57COncology
CELCCelcuity Inc56COncology
TGTXTG Therapeutics55COncology
GERNGeron Corporation54COncology
EXELExelixis Inc54COncology
CRNXCrinetics Pharmaceuticals53CEndocrinology
ALXOALX Oncology53COncology
MGNXMacroGenics Inc53COncology
BPMCBlueprint Medicines53COncology
INCYIncyte Corporation53COncology
BMYBristol-Myers Squibb51COncology
LBPHLongboard Pharmaceuticals48DOncology
CORTCorcept Therapeutics46DEndocrinology
ITOSiTeos Therapeutics45DOncology
ERASErasca Inc40DOncology
ZNTLZentalis Pharmaceuticals40DOncology
ONCYOncolytics Biotech, Inc.40DOncology
KPTIKaryopharm Therapeutics40DOncology
CGONCG Oncology, Inc.38DOncology
CRDFCardiff Oncology, Inc.38DOncology
MNKDMannKind Corporation36DEndocrinology
CATXPerspective Therapeutics36DOncology
CRVSCorvus Pharmaceuticals34FOncology
BCABBioAtla Inc34FOncology
CRBPCorbus Pharmaceuticals31FOncology
LTRNLantern Pharma28FOncology
CDTXCidara Therapeutics27FOncology
PYXSPyxis Oncology, Inc.26FOncology
CGEMCullinan Oncology25FOncology
FUSNFusion Pharmaceuticals24FOncology
LEGNLegend Biotech22FOncology
Not financial advice. All data and analysis provided by Guerilla Finance Inc. BiotechSign grades and scores are algorithmic signals only and do not constitute investment recommendations. Biotech investing involves significant risk, including the potential for complete loss of capital on binary FDA events. Always conduct your own due diligence before making investment decisions.